Air sampling at schools accurately detects flu and COVID-19 virus levels
Air samplers placed in school cafeterias provided an accurate look at a flu epidemic and at constant low levels of COVID-19 infections in a K-12 school district during the 2022-23 school year, according to a new study from researchers at the University of Wisconsin School of Medicine and Public Health.
New UW study examines COVID-19 vaccines in people with weakened immune systems
Researchers at the University of Wisconsin School of Medicine and Public Health are exploring the ideal vaccine booster strategy for immunosuppressed patients to protect those at higher risk of severe illness and complications from COVID-19 infection.
UW study seeks IBD patients to study effectiveness of updated COVID-19 vaccines
Researchers at the University of Wisconsin School of Medicine and Public Health are investigating how well the updated monovalent COVID-19 vaccines work for inflammatory bowel disease patients.
UW awards funding to improve maternal, child health throughout Wisconsin
The University of Wisconsin School of Medicine and Public Health has awarded four grants to help health systems and community partners in the state improve the health outcomes of mothers and their infants during the prenatal and postpartum periods.
Survey highlights changes in Wisconsinites’ alcohol consumption during COVID-19 pandemic
A new survey from the University of Wisconsin School of Medicine and Public Health details which populations experienced the greatest change in alcohol use during the COVID-19 pandemic, finding that higher-earning younger adults increased drinking the most.
Recognizing Clinical Trials Day: How major advances in medicine happen
When stakes are high, clinical trials rise to the challenge to keep moving medicine forward.
Hospital socioeconomic status, strain may increase death rate among ICU patients with COVID-19
Researchers at the University of Wisconsin School of Medicine and Public Health used hospital data from patients with COVID-19 admitted to intensive care units across the nation to identify factors linked to higher mortality rates within 28 days of admission.
Moderna COVID-19 vaccine pediatric clinical trial to focus on ages 6 months to 5 years
The KidCOVE phase three clinical trial at the University of Wisconsin School of Medicine and Public Health, which is evaluating the safety and effectiveness of the Moderna COVID-19 vaccine in children, has shifted focus to kids 6 months to 5 years old.
UW study examines allergic reactions to COVID-19 vaccines
Researchers from the UW School of Medicine and Public Health are seeking participants for a clinical study that examines whether the mRNA COVID-19 vaccines (Pfizer/BioNTech and Moderna) pose an increased risk for allergic reactions in individuals who are already considered “highly allergic.”
Pediatric research study aims to get medically complex K-12 students back to school safely
The last 18 months have been a struggle for 6-year-old Cade Moureau and his family.
UW study finds most patients with inflammatory bowel disease have immune response to COVID-19 vaccine; expands enrollment
The University of Wisconsin School of Medicine and Public Health is expanding a study investigating the efficacy of the COVID-19 vaccine for people who have inflammatory bowel disease (IBD).
UW selected as site for Moderna COVID-19 vaccine pediatric clinical trial
Aug. 16, 2021 update: Thanks to overwhelming interest from our community, UW Health and the UW School of Medicine and Public Health have already met the recruitment objectives for Moderna’s pediatric COVID-19 vaccine clinical trial. If your child is selected to be part of the trial, you will be contacted directly. Advancements in science, public health, and clinical care often cannot happen without a supportive and engaged citizenry, and we greatly appreciate this community’s ongoing efforts to help end this pandemic.